(Q48721170)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

review article

1 reference

title

NEDA status in highly active MS can be more easily obtained with autologous hematopoietic stem cell transplantation than other drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

author name string

Paolo A Muraro

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Riccardo Saccardi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Gianluigi Mancardi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

11 July 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

201-204

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

Is it time to target no evident disease activity (NEDA) in multiple sclerosis?

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Long-term assessment of no evidence of disease activity in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

High-dose immunosuppressive therapy and autologous hematopoietic cell transplantation for relapsing-remitting multiple sclerosis (HALT-MS): a 3-year interim report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Autologous haematopoietic stem-cell transplantation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

Association of nonmyeloablative hematopoietic stem cell transplantation with neurological disability in patients with relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458516645670

21 January 2018

Identifiers

DOI

10.1177/1352458516645670

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27207454%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference